OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

PR Newswire
April 8, 2022 — 20:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: pharmaceutical South Korea technology

Related News:

TRICORBRAUN APPOINTS KEVIN WEADICK AS PRESIDENT AND CEO

April 23, 2025 — 01:30

Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer’s Dementia

March 31, 2025 — 21:35

Wingderm® Presents at the 2025 AAD Annual Meeting, Strengthening Its Presence in the North American Market

March 11, 2025 — 01:00

APAC Hiring Intentions Strengthen as Employers Express Optimism for Q2 2025

March 11, 2025 — 00:01

Magcubic Disrupts the Smart Projector Market with Affordable Products for Everyone

March 11, 2025 — 00:00

Branch Unveils New Capabilities To Maximize Campaign ROI in a Privacy-First Era

March 5, 2025 — 23:03

United Soccer League and MAMMOTION Kick Off Partnership to Bring Superior Lawn Care Solutions to Soccer Communities

March 4, 2025 — 23:00

MWC Barcelona 2025: Fibocom Pioneers AI-powered Solutions with QuickTaste AI

March 4, 2025 — 22:55

REALTY ONE GROUP PARTNERS WITH REAL ESTATE’S LEADING INTERNATIONAL FRANCHISE EXPERT TO EXPAND GLOBALLY

March 4, 2025 — 04:23

Franchising and Licensing Asia (FLAsia) 2024